Abiraterone receives new NICE approval in ‘significant shift’ – The Pharmaceutical Journal

Written by

admin

in

  1. Abiraterone receives new NICE approval in ‘significant shift’  The Pharmaceutical Journal
  2. Prostate cancer drug that can halve death risk to be offered to thousands in England  The Guardian
  3. Pedro Barata, MD, on darolutamide efficacy across age…

Continue Reading

More posts